Featured Products
We are an integrated specialty pharmaceutical company focused on delivering value to our customers by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceuticals.
ANI Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/19/2021
ANI Pharmaceuticals Strengthens Leadership Team to Accelerate Future Growth
02/17/2021
$29.65
+0.0754 ( 0.255% )
Pricing delayed by 20 minutes
Last updated
03/03/2021 12:47 PM
